Download (3249Kb) - D-Scholarship@Pitt - University of Pittsburgh

More documents

Recommendations

Info

4.5.3 Biological Evaluation of Tricyclic Pyrroles The library of tricyclic pyrroles has been made available to a broad range of collaborators via the biological outreach program at the UPCMLD (Figure 4.3). Figure 4.3 List of assays performed on the tricyclic pyrroles 314{1-3,1-2,1-41}. Testing facility Assay type JMI Labs antibacterial assays Southern Research Institute antiviral assays: PDSP (Phychoactive Drug Screening Program) 40-50 assays influenza tacaribe west nile ponta toro denga yellow fever herpes-HSV, VZV, HSV-1 tuberculosis hepatitis C and B Testing facility Assay type NIH-Chemical Genomics Center various assays: Prx2 sOGT P450-cyp1a2 GR-EFC National Cancer Institute 60 cell-line cytotoxicity assays HIV protease inhibition ChemBank (Broad Institute-Harvard University) various assays: CREB reporter assay NOX superoxide generation yeast growth modification assay In addition, members of this library have been identified as inhibitors of cytoplasmic dynein by Prof. Day’s lab (University of Pittsburgh) and as inhibitors of human mitogen-activated protein kinase phosphatase-1 (MKP-1) by Prof. Lazo’s lab (University of Pittsburgh). Cytoplasmic dynein is an ATPase motor protein involved in multiple cellular processes. 216 For example, dynein provides force for nuclear envelope breakdown, formation in the mitotic spindle and chromosomal segregation. 216d In addition, dynein is responsible for intracellular transport of organelles, protein complexes etc. Small molecules that interfere with dynein activity can be used to study its important functions in the cell. Unfortunately, there are only a few known inhibitors of dynein, characterized with low activity and/or lack of specificity. 217 Therefore, the discovery of structurally novel inhibitors of dynein is an important area of research. Using a cell-based phenotypic assay, Day and coworkers have identified 126
tricyclic pyrrole 314{3,2,26} (Figure 4.4) as an inhibitor of cytoplasmic dynein activity. 218 Concentration-dependent experiments have shown that 314{3,2,26} uncompetitively inhibits dynein’s ATPase activity with IC50 value of 2.0 µM. z These very encouraging results have prompted further studies into the mechanism of action of 314{3,2,26}. Figure 4.4 Structures of bioactive tricyclic pyrroles. MeO BzN MeO2C H H O N O N 314{3,2,26} dynein ATPase inhibitor IC 50 = 2.0 µM F BzN MeO2C H H N O S N 314{2,1,27} MKP-1 inhibitor IC 50 = 8.0 µM Br H F F BzN MeO2C H N O 314{2,1,19} MKP-1 inhibitor IC 50 = 8.3 µM Mitogen-activated protein kinases (MAPK) are important cellular proteins that act as effectors of various growth factors, stress detectors and drug sensors in the cell. 219 Their function is regulated by a number of mitogen-activated protein kinase phosphatases (MKPs). MKP-1 is a dual specificity phosphatase, meaning it is capable of dephosphorylating both phosphotyrosine and phosphothreonine residues on a same protein substrate. Furthermore, MKP-1 expression is elevated in prostate, breast, gastric and renal cancers. 220 Therefore, MKP-1 is an important target for inhibition by small molecules in order to further understand its function and potentially generate lead structures for cancer chemotherapy. However, MKP-1 has evaded inhibition by small molecules and the few known inhibitors are not potent and/or not selective. 221 Lazo and coworkers have screened 172 members of the tricyclic pyrrole library in an effort to identify novel inhibitors of MKP-1. 222 The study resulted in identification of 22 compounds with IC50 z Biological tests were performed by Mr. Guangyu Zhu under the supervision of Professor Billy W. Day. 127 N F
Page 1 and 2:
TRANSITION METAL-CATALYZED REACTION
Page 3 and 4:
Transition Metal-Catalyzed Reaction
Page 5 and 6:
List of Abbreviations Ac acetyl AcO
Page 7 and 8:
Table of Contents 1.0 Introduction.
Page 9 and 10:
Appendix A : X-ray crystal structur
Page 11 and 12:
Table 4.8 Rh(I)-catalyzed cyclocarb
Page 13 and 14:
List of Schemes Scheme 1.1 Three fo
Page 15 and 16:
Scheme 3.24 Preparation of amide-te
Page 17 and 18:
Scheme 4.16 Formation of bicyclo[5.
Page 19 and 20:
1.0 Introduction 1.1 The Role of Di
Page 21 and 22:
According to these guidelines, the
Page 23 and 24:
Scheme 1.1 Three forms of diversity
Page 25 and 26:
Another example from the Schreiber
Page 27 and 28:
1.1.1 Transition Metal-Catalyzed Re
Page 29 and 30:
37, , such reactions include transi
Page 31 and 32:
the proximal olefin of allenyne 38
Page 33 and 34:
2.0 Design and Synthesis of the Piv
Page 35 and 36:
The allenic amino acid derivatives
Page 37 and 38:
This protocol proved particularly u
Page 39 and 40:
ZnCl2, which results in a Zn-chelat
Page 41 and 42:
Scheme 2.7 Synthesis of trisubstitu
Page 43 and 44:
THF), the yield was increased from
Page 45 and 46:
the terminus of the alkyne led to d
Page 47 and 48:
N-Alkylation of the glycine-derived
Page 49 and 50:
circumvent this issue, variants suc
Page 51 and 52:
BINAP as a chiral ligand to obtain
Page 53 and 54:
stereochemistry of the exocyclic ol
Page 55 and 56:
3.2 Rhodium(I)-Catalyzed Allenic Cy
Page 57 and 58:
exocyclic olefin geometry is not re
Page 59 and 60:
3.2.1 Preparation of Enol-ether Tri
Page 61 and 62:
Scheme 3.15 Synthesis of cycloisome
Page 63 and 64:
Scheme 3.17 Cycloisomerization of a
Page 65 and 66:
Scheme 3.19 Tandem cycloadditions o
Page 67 and 68:
Scheme 3.21 Intermolecular Diels-Al
Page 69 and 70:
attractive, since additional functi
Page 71 and 72:
increased yield of the triene (47%)
Page 73 and 74:
as an isobutyl-amide 155b was prepa
Page 75 and 76:
group) demonstrated that this cyclo
Page 77 and 78:
in 1M HCl/dioxane (1 : 1) for 1h, t
Page 79 and 80:
ppm (dd, J = 7.1, 4.6 Hz, 1H) assig
Page 81 and 82:
http://ccc.chem.pitt.edu/). Using f
Page 83 and 84:
Notably, exclusive cycloisomerizati
Page 85 and 86:
intermediate in the reaction we sou
Page 87 and 88:
epulsive dipole interactions (Schem
Page 89 and 90:
Table 3.4 Diels-Alder reactions of
Page 91 and 92:
allenic Alder-ene reaction, ene-all
Page 93 and 94: Figure 3.4 Examples of natural prod
Page 95 and 96: species onto the proximal double bo
Page 97 and 98: Scheme 3.49 Rh(I)-catalyzed ene rea
Page 99 and 100: y Magnus 144 and it involves the in
Page 101 and 102: usually is DMSO. Heating to 100 ºC
Page 103 and 104: that require high pressures of CO.
Page 105 and 106: In contrast to the Mo(CO)6-mediated
Page 107 and 108: Scheme 4.15 Rh(I)-catalyzed allenic
Page 109 and 110: 4.2 Rhodium(I)-Catalyzed Cyclocarbo
Page 111 and 112: lack of double bond selectivity, si
Page 113 and 114: Table 4.2 Cyclocarbonylation reacti
Page 115 and 116: Notably, the allenic cyclocarbonyla
Page 117 and 118: Scheme 4.22 Cyclocarbonylation reac
Page 119 and 120: neat or in solution. This decomposi
Page 121 and 122: the newly synthesized fulvenes (e.g
Page 123 and 124: stereocenters and mixture of E/Z is
Page 125 and 126: proximal double bond to give α-alk
Page 127 and 128: the methyl ester and Ha are syn. Sc
Page 129 and 130: that the major diastereomer in the
Page 131 and 132: We were motivated to first examine
Page 133 and 134: Scheme 4.42 Synthesis of pyrrole 29
Page 135 and 136: periodic acid (H5IO6). 209 These hi
Page 137 and 138: eaction failed to go to completion,
Page 139 and 140: 4.5.2 Synthesis of a Library of Tri
Page 141 and 142: diketones 312{1-3,1-2} in yields ra
Page 143: Figure 4.2 Distribution for physico
Page 147 and 148: 4.6 Synthesis of α-Alkylidene Cycl
Page 149 and 150: anched and linear carboxylic acid i
Page 151 and 152: eactivity of the species prepared i
Page 153 and 154: considerably lower than the ratio o
Page 155 and 156: diastereomer. Next, allenyne 328 wa
Page 157 and 158: Conclusions In summary, we have dem
Page 159 and 160: Experimental Section General Method
Page 161 and 162: General procedure A for esterificat
Page 163 and 164: F Bz N H 56f 2-Benzoylamino-3-(4-fl
Page 165 and 166: MeO2C Bz N H 58c 2-Benzoylamino-2-m
Page 167 and 168: MeO MeO2C Bz N H 58e 2-Benzoylamino
Page 169 and 170: mL) and MeOH (10 mL) instead of sat
Page 171 and 172: hexanes-EtOAc, 19 : 1 to 4 : 1, v/v
Page 173 and 174: which was immediately used in the C
Page 175 and 176: Boc TMS N H Bn 64f tert-Butyl-1-((4
Page 177 and 178: MeI (38 µL, 0.62 mmol). Yield 65a
Page 179 and 180: with brine and concentrated under v
Page 181 and 182: H MeO 2C • H Bn NHBoc tert-Butyl-
Page 183 and 184: TMS MeO 2C • 70 H H NHBoc 2-tert-
Page 185 and 186: 185 (10), 141 (21), 57 (100); EI-HR
Page 187 and 188: dispersion in mineral oil, 1.0 mmol
Page 189 and 190: EI-HRMS calcd for C30H26NO3 m/z [M-
Page 191 and 192: CbzN MeO 2C Me 73h 2-[Benzyloxycarb
Page 193 and 194: CbzN MeO 2C Me 2-(Benzyloxycarbonyl
Page 195 and 196:
dispersion in mineral oil, 3.85 mmo
Page 197 and 198:
completion of the addition, the rea
Page 199 and 200:
BzN MeO 2C S 74h 2-(Benzoylprop-2-y
Page 201 and 202:
BzN MeO 2C Bn 75b 2-(Allylbenzoylam
Page 203 and 204:
BzN MeO 2C TBSO 75e 2-(Benzoylbut-2
Page 205 and 206:
Hz, 1H), 5.85 (s, 1H), 5.52 (dd, J
Page 207 and 208:
1H), 3.69 (s, 3H), 1.58 (d, J = 7.1
Page 209 and 210:
µmol), [Rh(CO)2Cl]2 (1 mg, 3 µmol
Page 211 and 212:
1.25 (m, 6H), 0.88 (t, J = 6.9 Hz,
Page 213 and 214:
6.72 (d, J = 7.6 Hz, 0.5H), 6.68 (d
Page 215 and 216:
BzN MeO2C Bn 122a Methyl-2-(N-(but-
Page 217 and 218:
Bz N MeO2C Bn 1-Benzoyl-2-benzyl-4-
Page 219 and 220:
13.9, 5.3 Hz, 1H), 2.51-2.47 (m, 1H
Page 221 and 222:
15 min the solvent was removed unde
Page 223 and 224:
Benzoyl chloride (0.169 mL, 1.46 mm
Page 225 and 226:
mg, 0.11 mmol), [Rh(CO)2Cl]2 (4 mg,
Page 227 and 228:
mL). kk The aqueous layer was extra
Page 229 and 230:
ºC. After quenching the reaction b
Page 231 and 232:
129.8, 129.0, 128.7, 128.4, 126.2,
Page 233 and 234:
MeO 2C O O O N H N R 1 O N Ph [10c-
Page 235 and 236:
The crude residue was purified by f
Page 237 and 238:
14.4 Hz, 1H), 3.49-3.39 (m, 2H), 3.
Page 239 and 240:
1H), 5.49 (dd, J = 17.3, 1.8 Hz, 1H
Page 241 and 242:
was stirred at rt for 1 h when it w
Page 243 and 244:
BzN HOOC 2-(N-(but-2-ynyl)benzamido
Page 245 and 246:
°C and DIBAL-H (0.440 mL of a 1.0M
Page 247 and 248:
129 (62), 91 (100); EI-HRMS calcula
Page 249 and 250:
(d, J = 18.0 Hz, 1H), 4.14 (d, J =
Page 251 and 252:
4.98 (dt, J = 7.7, 5.1 Hz, 1H), 4.1
Page 253 and 254:
N Bz MeO2C OTBS 214 1-Benzoyl-2-(te
Page 255 and 256:
270a (major diastereomer-eluting fi
Page 257 and 258:
CDCl3): δ 7.42-7.17 (m, 13H), 7.04
Page 259 and 260:
18.6 Hz, 1H), 4.34 (d, J = 18.0 Hz,
Page 261 and 262:
Bz N MeO2C 2-Benzoyl-3,7-dimethyl-6
Page 263 and 264:
v/v) afforded a mixture of compound
Page 265 and 266:
(435 mg, 1.21 mmol), DMSO (429 µL,
Page 267 and 268:
4.02 (s, 1H), 3.88 (s, 3H), 1.82 (s
Page 269 and 270:
(207 mg, 96%) consisting of 287e (7
Page 271 and 272:
procedure O, using: 74f (110 mg, 0.
Page 273 and 274:
Bz N O H CO2Me BocN 287i 3-(2-Benzo
Page 275 and 276:
4.17 (d, J = 15.0 Hz, 1H), 4.10 (d,
Page 277 and 278:
137.1, 136.9, 130.4, 129.8, 128.5,
Page 279 and 280:
H BzN MeO2C Bn H N C3H7 298b CO 2Me
Page 281 and 282:
NMR (75 MHz, CDCl3): δ 172.3, 169.
Page 283 and 284:
following the general procedure Q,
Page 285 and 286:
H BzN MeO2C Bn H 5-Benzoyl-1,4-dibe
Page 287 and 288:
119.9, 114.1, 109.9, 108.6, 73.0, 5
Page 289 and 290:
4.11 (m, 1H), 4.07-3.98 (m, 1H), 3.
Page 291 and 292:
126.8, 126.2, 109.0, 72.9, 58.7, 56
Page 293 and 294:
NMR (75 MHz, CDCl3): δ 172.2, 169.
Page 295 and 296:
3.0 Hz, 1H), 5.82-5.80 (m, 1H), 5.2
Page 297 and 298:
87%). The diastereomeric ratio (288
Page 299 and 300:
APPENDIX A: X-ray crystal structure
Page 301 and 302:
APPENDIX B: X-ray crystal structure
Page 303 and 304:
APPENDIX C: X-ray crystal structure
Page 305 and 306:
APPENDIX D: X-ray crystal structure
Page 307 and 308:
APPENDIX E: X-ray crystal structure
Page 309 and 310:
APPENDIX F: QikProp property predic
Page 311 and 312:
1 H and 13 C NMRs of 74b 293
Page 313 and 314:
1 H and 13 C NMRs of 111a 295
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
1 H and 13 C NMRs of 270h 303
Page 323 and 324:
Page 325 and 326:
1 H and 13 C NMRs of 307 307
Page 327 and 328:
1 H and 13 C NMRs of 308n 309
Page 329 and 330:
10. (a) Burke, M. D.; Schreiber, S.
Page 331 and 332:
Hu, Y. J. Comb. Chem. 2006, 8, 286.
Page 333 and 334:
49. For reviews on reactions of all
Page 335 and 336:
69. (a) Trost, B. M.; Lautens, M.;
Page 337 and 338:
containing cross-conjugated trienes
Page 339 and 340:
Vaillancourt, J.; Rasper, D. M.; Ta
Page 341 and 342:
130. Oppolzer, W.; Snieckus, V. Ang
Page 343 and 344:
149. (a) Hicks, F. A.; Buchwald, S.
Page 345 and 346:
Maiese, W. M. J. Antibiot. 2000, 53
Page 347 and 348:
192. The mechanism of decomposition
Page 349 and 350:
Boger, D. L.; Boyce, C. W.; Labroli
Page 351:
Generated Inhibitors of Human Mitog
show all

Download (3249Kb) - D-Scholarship@Pitt - University of Pittsburgh

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?